In addition, although alterations in the expression of SPTAN1 have been described in a variety of tumours and tissues [31,32,33,34,35], the directionality of these changes (upregulation vs. downregulation) defies any clear classification [11]. The gene discussed is SPTAN1; the disease is neoplasm.